Mark A Roth

US Patent:

7577961, Aug 18, 2009

Filed:

Aug 25, 2004

Appl. No.:

10/926231

Inventors:

Robert K. Bissett - Peabody MA, US
Ryan C. Shoemaker - Acton MA, US
Mark L. Roth - Brooklyn NY, US

Assignee:

Sun Microsystems, Inc. - Santa Clara CA

International Classification:

G06F 9/44
G06F 11/00
G06F 7/38

US Classification:

719318, 719316, 714 48, 712244

Abstract:

In a programmed computer system, normal processing results generated by a called method are returned to one or more calling methods by an exception rather than by the more conventional single-type return value. The programmer is granted flexibility through the ability to use multiple normal return types while retaining strong data typing. Better programming practices are promoted through the use of a single exception-technique for handling normal results as well as abnormal (i. e. error) results. The disclosed technique can be used with existing programming languages/environments such as the Java language, and can provide a basis for new languages/environments that are specifically tailored to this processing technique.

US Patent:

20010049796, Dec 6, 2001

Filed:

May 31, 2001

Appl. No.:

09/873095

Inventors:

Mark Roth - Lowell MA, US
Ronald Monzillo - Lexington MA, US
Kevin Osborn - Newton Highlands MA, US
William Shannon - Los Altos CA, US

International Classification:

G06F012/00

US Classification:

713/201000

Abstract:

A non-programmatic method for bootstrapping a user database from the web tier using pass-through server-provided form targets is disclosed. A “form target,” used in this context, is the submission destination of an HTML form, submitted via HTTP (typically this is called an “action” in HTTP). The “form target” is usually the name of a CGI script, or an alias to an ASP, Servlet or JSP on the server, which will handle a form request. When the user submits a form via HTTP, the application server will extract security data and then pass control back to an application success target or a failure target.

US Patent:

20040047878, Mar 11, 2004

Filed:

Sep 26, 2003

Appl. No.:

10/672489

Inventors:

Ruitang Deng - Old Lyme CT, US
Mark Roth - Cambridge MA, US
Michael Shepperd - Ringwood, AU
David Wheeler - East Lyme CT, US
Terecita Yule - Norwich CT, US
Eric Fuog - Gales Ferry CT, US
Suresh Jeevarathnam - Waterford CT, US
Anthony Johnson - North Stonington CT, US
William Koertje - Ledyard CT, US

International Classification:

A61K039/21

US Classification:

424/187100

Abstract:

The present invention is directed to vaccine compositions that can be used to protect cats against feline immunodeficiency virus. More particularly, the present invention relates to polynucleotide molecules that can be used as vaccine components against feline immunodeficiency virus.

US Patent:

20040076632, Apr 22, 2004

Filed:

Sep 26, 2003

Appl. No.:

10/673023

Inventors:

Ruitang Deng - Old Lyme CT, US
Mark Roth - Cambridge MA, US
Michael Shepperd - Ringwood, AU
David Wheeler - East Lyme CT, US
Terecita Yule - Norwich CT, US
Eric Fuog - Gales Ferry CT, US
Suresh Jeevarathnam - Waterford CT, US
Anthony Johnson - North Stonington CT, US
William Koertje - Ledyard CT, US

International Classification:

A61K039/42
C07K016/10

US Classification:

424/160100, 530/388350

Abstract:

The present invention is directed to vaccine compositions that can be used to protect cats against feline immunodeficiency virus. More particularly, the present invention relates to polynucleotide molecules that can be used as vaccine components against feline immunodeficiency virus.

US Patent:

20040102411, May 27, 2004

Filed:

Sep 26, 2003

Appl. No.:

10/673008

Inventors:

Ruitang Deng - Old Lyme CT, US
Eric Fuog - Gales Ferry CT, US
Suresh Jeevarathnam - Waterford CT, US
Anthony Johnson - North Stonington CT, US
William Koertje - Ledyard CT, US
Mark Roth - Cambridge MA, US
Michael Shepperd - Ringwood, AU
David Wheeler - East Lyme CT, US
Terecita Yule - Norwich CT, US

International Classification:

A61K048/00

US Classification:

514/044000

Abstract:

The present invention is directed to vaccine compositions that can be used to protect cats against feline immunodeficiency virus. More particularly, the present invention relates to polynucleotide molecules that can be used as vaccine components against feline immunodeficiency virus.